Cat. No. | Product name | CAS No. |
DC9520 |
NKP608
NKP608 is a non-peptidic derivative of 4-aminopiperidine which acts as a selective, specific and potent antagonist at the neurokinin-1 (NK-1) receptor both in vitro(IC50=2.6 nM) and in vivo. |
177707-12-9 |
DC26132 |
NLRP3 Inflammasome Inhibitor I
NLRP3 Inflammasome Inhibitor I, an intermediate substrate in the synthesis of glyburide which is free of the cyclohexylurea moiety involved in insulin release, is a novel inhibitor of the NLRP3 inflammasome. |
16673-34-0 |
DC22177 |
NLY01
NLY01 (NLY-01, GLP1R agonist NLY01) is a potent, brain-penetrant long-acting GLP1R agonist, protects against the loss of dopaminergic neurons and behavioral deficits in the α-synuclein preformed fibril (α-syn PFF) mouse model of sporadic Parkinson's disea |
|
DC11134 |
NMac1
NMac1 (Nm23 activator 1) is a small molecule activator of Nm23/NDPK, directly binds to Nm23-H1 and activates NDPK activity of recombinant Nm23-H1 with EC50 of 10.7 uM. |
1332290-68-2 |
DC20105 |
NMDAR antagonist 1
Featured
NMDAR antagonist 1 is a potent and orally bioavailable NR2B-selective NMDAR antagonist. |
|
DC8829 |
Betahistine EP Impurity C(NSC19005)
Featured
N-Methyl-N,N-bis(2-pyridylethyl)amine is used as a reagent in the preparation of copper pyridylmethylethylenediamine dicyanamido polymeric complexes. |
5452-87-9 |
DC12351 |
NMI 8739
NMI 8739 is a dopamine D2 autoreceptor agonist, which is an amine conjugate of the DHA carrier and the neurotransmitter dopamine. |
129024-87-9 |
DC21390 |
NMS-P293
NMS-P293 is a novel potent and selective PARP-1 inhibitor possessing >200-fold selectivity versus PARP-2. |
|
DC23556 |
NMS-P645
NMS-P645 is a novel selective inhibitor of pan-Pim kinases with IC50 of 3/73/12 nM for Pim1/2/3, respectively. |
1482518-95-5 |
DC8445 |
NMS-P937 (NMS1286937)
Featured
NMS-P937 (NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Phase 1. |
1034616-18-6 |
DC21224 |
NMT1 inhibitor B13
NMT1 inhibitor B13 (LCL4) is a myristoylCoA analog that acts as a small molecule inhibitor of NMT1 with IC50 of 77.6 uM, blocks Src myristoylation and Src localization to the cytoplasmic membrane. |
35922-06-6 |
DC21391 |
NNC 05-2090 hydrochloride
Featured
NNC 05-2090 is a potent selective GABA transporter inhibitor of mGAT2 with Ki of 1.4 uM. |
184845-18-9 |
DC22893 |
NNC-0640
NNC-0640 (NNC 0640, NNC0640) is a potent, selective glucagon receptor (GCGR) negative allosteric modulator with IC50 of 69.2 nM. |
307986-98-7 |
DC21392 |
NNC-711
Featured
NNC-711 is a potent and selective inhibitor of GABA uptake by GAT-1 with IC50 of 0.04 uM. |
145645-62-1 |
DC11386 |
NNZ-2591
Featured
NNZ2591 (cyclo-L-glycyl-L-2-allylproline)1 is an investigational synthetic analog of cyclic glycine-proline (cGP), a breakdown product of human insulin-like growth factor 1 (IGF-1), that has been chemically modified to increase its half-life, stability, and oral bioavailability. |
1821796-28-4 |
DC12198 |
N-Oleoyl glycine
N-Oleoyl glycine is a lipoamino acid, which stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte. |
2601-90-3 |
DC8178 |
Beclabuvir(BMS-791325)
non-nucleoside inhibitor of the NS5B |
958002-33-0 |
DC9342 |
Noopept
Noopept (GVS-111) is a medication promoted and prescribed in Russia and neighbouring countries as a nootropic. |
157115-85-0 |
DC9579 |
Nortadalafil
Featured
Nortadalafil is demethyl Tadalafil, which is a PDE5 inhibitor, currently marketed in pill form for treating erectile dysfunction (ED) under the name Cialis; and under the name Adcirca for the treatment of pulmonary arterial hypertension. IC50 value: Ta |
171596-36-4 |
DC8848 |
Nosiheptide
Nosiheptide is a bicyclic thiopeptide antibiotic produced by several species of actinomycetes, notably Streptomyces. |
56377-79-8 |
DC11016 |
NOSO-502
NOSO-502 (NOSO502) is a novel inhibitor of bacterial translation, has MIC values of 0.5-4 ug/ml against standard Enterobacteriaceae strains and carbapenem-resistant Enterobacteriaceae (CRE) isolates that produce KPC, AmpC, or OXA enzymes and metallo-β-lactamases. |
1894081-09-4 |
DC11212 |
NP161
NP161 is a potent and selective inhibitor of extracellular TRX (Thioredoxin 1) in vitro with IC50 of 0.54 uM. |
1421763-05-4 |